CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ildong Holdings Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ildong Holdings Co Ltd
2, Baumoe-ro 27-gil, Seocho-gu
Phone: +82 25263114p:+82 25263114 SEOUL, 06752  South Korea Ticker: 000230000230
Business Summary
Ildong Holdings Co., Ltd., formerly Ildong Pharmaceuticals Co., Ltd., is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products mainly include general drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, anti-histamines, antipyretics, analgesics, respiratory medications, endocrine medications, psychoneurological medications, dermatological medications, urologic medications, antibiotics and others. It also provides raw materials, such as synthesises, probiotics and others. In addition, through its subsidiaries, it engages in the advertising agency, medical equipment distribution, software development, food processing and other businesses.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
7311 Advertising agencies
5047 Medical, dental, and hospital equipment and supplies
7372 Prepackaged software
2023 Dry, condensed, and evaporated dairy products
3639 Household appliances, not elsewhere classified
8999 Services, not elsewhere classified
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman Won YeongYoon 83 1/1/2021 1/1/2021
Chief Executive Officer, Director Dae ChangPark 71 3/25/2022 3/15/2013
Managing Director Gyu HwanChoi 60
9 additional Officers and Directors records available in full report.

Business Names
Business Name
000230
Ildong Pharmaceutical Co., Ltd.

General Information
Number of Employees: 84 (As of 9/30/2023)
Outstanding Shares: 11,292,090 (As of 6/30/2024)
Shareholders: 18,683
Stock Exchange: KRX
Fax Number: +82 25263030


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024